Canada Life’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,299,950
| Closed | -$106M | – | 2050 |
|
|
2024
Q3 | $106M | Buy |
1,299,950
+64,850
| +5% | +$5.64M | 0.19% | 106 |
|
|
2024
Q2 | $132M | Sell |
1,235,100
-6,210
| -0.5% | -$596K | 0.25% | 74 |
|
|
2024
Q1 | $121M | Sell |
1,241,310
-316,000
| -20% | -$27.8M | 0.24% | 74 |
|
|
2023
Q4 | $121M | Sell |
1,557,310
-26,750
| -2% | -$1.82M | 0.27% | 71 |
|
|
2023
Q3 | $99.3M | Sell |
1,584,060
-2,420
| -0.2% | -$159K | 0.24% | 81 |
|
|
2023
Q2 | $103M | Sell |
1,586,480
-56,600
| -3% | -$3.19M | 0.24% | 78 |
|
|
2023
Q1 | $87.2M | Sell |
1,643,080
-42,690
| -3% | -$2.1M | 0.22% | 92 |
|
|
2022
Q4 | $71.2M | Buy |
1,685,770
+463,250
| +38% | +$19.4M | 0.19% | 114 |
|
|
2022
Q3 | $44.7M | Sell |
1,222,520
-7,900
| -0.6% | -$352K | 0.13% | 162 |
|
|
2022
Q2 | $52.5M | Sell |
1,230,420
-35,370
| -3% | -$1.68M | 0.14% | 150 |
|
|
2022
Q1 | $71.7M | Sell |
1,265,790
-24,670
| -2% | -$1.44M | 0.15% | 137 |
|
|
2021
Q4 | $92.6M | Sell |
1,290,460
-75,310
| -6% | -$4.72M | 0.19% | 100 |
|
|
2021
Q3 | $78.2M | Buy |
1,365,770
+1,370
| +0.1% | +$83.3K | 0.18% | 106 |
|
|
2021
Q2 | $88.7M | Sell |
1,364,400
-46,130
| -3% | -$2.91M | 0.2% | 99 |
|
|
2021
Q1 | $83.5M | Sell |
1,410,530
-466,150
| -25% | -$25.4M | 0.2% | 102 |
|
|
2020
Q4 | $88.5M | Sell |
1,876,680
-366,570
| -16% | -$15.4M | 0.17% | 134 |
|
|
2020
Q3 | $74.4M | Buy |
2,243,250
+49,090
| +2% | +$1.69M | 0.16% | 141 |
|
|
2020
Q2 | $70.7M | Buy |
2,194,160
+10,770
| +0.5% | +$294K | 0.16% | 140 |
|
|
2020
Q1 | $52.6M | Buy |
2,183,390
+79,470
| +4% | +$2.29M | 0.14% | 155 |
|
|
2019
Q4 | $61.1M | Buy |
2,103,920
+276,720
| +15% | +$7.35M | 0.13% | 168 |
|
|
2019
Q3 | $42.3M | Sell |
1,827,200
-96,080
| -5% | -$2.02M | 0.1% | 227 |
|
|
2019
Q2 | $36.1M | Buy |
1,923,280
+18,590
| +1% | +$353K | 0.08% | 249 |
|
|
2019
Q1 | $34M | Buy |
1,904,690
+333,390
| +21% | +$5.56M | 0.09% | 226 |
|
|
2018
Q4 | $20.8M | Sell |
1,571,300
-237,220
| -13% | -$3.4M | 0.06% | 299 |
|
|
2018
Q3 | $27.5M | Sell |
1,808,520
-732,660
| -29% | -$12.5M | 0.07% | 288 |
|
|
2018
Q2 | $44M | Sell |
2,541,180
-747,950
| -23% | -$14.4M | 0.1% | 206 |
|
|
2018
Q1 | $66.8M | Buy |
3,289,130
+116,850
| +4% | +$2.31M | 0.16% | 147 |
|
|
2017
Q4 | $58.3M | Buy |
3,172,280
+538,440
| +20% | +$10.6M | 0.14% | 165 |
|
|
2017
Q3 | $48.2M | Buy |
2,633,840
+45,370
| +2% | +$736K | 0.12% | 187 |
|
|
2017
Q2 | $36.5M | Buy |
2,588,470
+704,040
| +37% | +$10.3M | 0.1% | 225 |
|
|
2017
Q1 | $24.2M | Buy |
1,884,430
+190,900
| +11% | +$2.24M | 0.07% | 288 |
|
|
2016
Q4 | $18M | Buy |
1,693,530
+425,430
| +34% | +$4.32M | 0.05% | 346 |
|
|
2016
Q3 | $12M | Buy |
1,268,100
+31,760
| +3% | +$289K | 0.04% | 440 |
|
|
2016
Q2 | $10.4M | Buy |
1,236,340
+302,320
| +32% | +$2.43M | 0.03% | 467 |
|
|
2016
Q1 | $7.71M | Buy |
934,020
+2,090
| +0.2% | +$15.2K | 0.03% | 475 |
|
|
2015
Q4 | $7.41M | Sell |
931,930
-4,700
| -0.5% | -$35.3K | 0.03% | 464 |
|
|
2015
Q3 | $6.13M | Sell |
936,630
-674,710
| -42% | -$4.94M | 0.02% | 499 |
|
|
2015
Q2 | $13.1M | Buy |
1,611,340
+584,090
| +57% | +$4.59M | 0.05% | 366 |
|
|
2015
Q1 | $7.2M | Sell |
1,027,250
-19,240
| -2% | -$152K | 0.02% | 512 |
|
|
2014
Q4 | $8.29M | Buy |
1,046,490
+19,130
| +2% | +$148K | 0.03% | 464 |
|
|
2014
Q3 | $7.69M | Buy |
1,027,360
+192,790
| +23% | +$1.38M | 0.03% | 494 |
|
|
2014
Q2 | $5.62M | Sell |
834,570
-215,600
| -21% | -$1.29M | 0.02% | 574 |
|
|
2014
Q1 | $5.75M | Buy |
1,050,170
+238,610
| +29% | +$1.27M | 0.02% | 552 |
|
|
2013
Q4 | $4.44M | Buy |
811,560
+45,740
| +6% | +$241K | 0.02% | 613 |
|
|
2013
Q3 | $3.91M | Buy |
765,820
+759,200
| +11,468% | +$3.71M | 0.02% | 609 |
|
|
2013
Q2 | $30K | Buy |
+6,620
| New | +$29.9K | ﹤0.01% | 753 |
|
Other funds holding LRCX
Canada Life's LRCX Position: Q4 2024 in Review
Canada Life sold out of Lam Research (LRCX) in Q4 2024, closing a stake of 1,299,950 shares — an estimated $106M sold.
Canada Life first reported a position in LRCX in Q2 2013 and held it in 46 quarters. The position peaked at $132M in Q2 2024. 1,690 funds tracked by Wall St. Rank hold LRCX as of Q4 2024.
- Canada Life reported no remaining Lam Research position as of Q4 2024 after selling out during the quarter.
- Canada Life sold 1,299,950 Lam Research shares in Q4 2024, an estimated $106M.
- Canada Life first reported a position in Lam Research in Q2 2013 and held it in 46 quarters.
- Canada Life's Lam Research position peaked at $132M in Q2 2024.
- 1,690 funds tracked by Wall St. Rank held Lam Research as of Q4 2024.
Based on Canada Life's 13F filing for Q4 2024, filed 13 Feb 2025.